Objective: To investigate the relationship between blood 25-hydroxyvitamin D-3(25-OHD-3) and gestational diabetes mellitus(GDM) in women in the early and mid trimesters of pregnancy. Methods: The parturients who had routine pregnancy examination in our hospital from January 2018 to December 2021 were randomly selected as the objects of study. The levels of fasting blood glucose(FBG) and glycosylated hemoglobin(HbAlc) were tested in 8-12 weeks of gestation, while the levels of 25-OHD-3 were detected in 13-15 weeks of gestation. 75 g oral glucose tolerance test(OGTT), including FBG, 1 hour postprandial blood glucose(1 h PBG), and 2 hours postprandial blood glucose(2 h PBG), was performed in 24-28 weeks of gestation, and serum 25-OHD-3 was detected in fasting, 1 hour and 2 hours after taking sugar water. Subsequently, they were divided into GDM group(n=100) and control group(n=100), according to the screening results. The differences of FBG, HbAlc in the early trimester, 25-OHD-3 in the mid and empty, 1 h and 2 h after taking sugar water blood glucose and 25-OHD-3 in the mid to late trimester of pregnancy were compared between the two groups.The relationship between serum 25-OHD-3 level and GDM was analyzed. Results: The levels of FBG, HbAlc and OGTT in early trimester of pregnancy in the GDM group were increased,compared with those in the control group(P<0.05); The level of serum 25-OHD-3 in the GDM group was lower than that in the control group, with statistical difference between the two groups(P<0.05); Pregnant women in the two groups were both deficient and insufficient in serum 25-OHD-3. The serum 25-OHD-3 adequacy rate was 6.00% in the GDM group and 7.00% in the control group, the deficiency rate was 30.00% in the GDM group, 32.00% in the control group, and the insufficient rate was 64.00% in the GDM group and 61.00% in the control group. Comprehensive comparison showed that there were no significant differences in the serum 25-OHD-3 adequacy rate, deficiency rate and insufficient rate between the two groups(P>0.05). In the GDM group,25-OHD-3 level in normal FBG group was significantly higher than that in abnormal FBG group(P<0.05); No significant difference was revealed for the level of 25-OHD-3 between the normal and abnormal blood sugar group, while 1 h and 2 h after taking sugar(P>0.05). Conclusion: With gestational age increasing, the serum 25-OHD-3 levels of pregnant women gradually decreased, and the lower serum 25-OHD-3 level in the mid trimester is closely related to the occurrence of GDM. In the mid trimester of pregnancy, the low vitamin D level can increase the incidence of GDM. For high-risk groups, it is necessary to strengthen early monitoring, active supplement of vitamin D, and to prevent and suppress the occurrence of GDM. |
[1] AL-SHAFEI A I, RAYIS D A, MOHIELDEIN A H, et al.Maternal early pregnancy serum level of 25-Hydroxyvitamin D and risk of gestational diabetes mellitus[J].International Journal of Gynecology & Obstetrics, 2020, 104(27):201-203.
[2] 王楠, 全莉梅, 章根琴, 等.妊娠期糖尿病患者血清25羟维生素D3及血脂水平分析[J].中华全科医学, 2021, 19(7):1147-1149.
[3] 陈婧, 赵英俊, 陈燕萍, 等.妊娠早期血红蛋白、25-羟维生素D3与妊娠期糖尿病和分娩方式关系的研究[J].临床血液学杂志, 2021, 34(6):407-411.
[4] 叶瑛瑛, 王金辉, 王丽君, 等.孕妇血维生素D水平与妊娠期糖尿病相关性研究[J].中华全科医学, 2021, 19(1):77-79, 119.
[5] 王余娜, 高显舜, 姚可荣.妊娠期糖尿病患者血清维生素D、白细胞介素-17水平与胰岛素抵抗指数相关性研究[J].陕西医学杂志, 2020, 49(11):1429-1431, 1439.
[6] 贾秦亮, 段美婷, 谢云.孕中期维生素D及微量元素水平与GDM发生的相关性分析[J].临床误诊误治, 2020, 33(12):79-85.
[7] CORONA A, DUEAS S, GONZÁLEZ-MORENO J, et al.Levels of 25-hydroxyvitamin D in pregnant womens with and without gestational diabetes mellitus[J].Ginecología y Obstetricia de México, 2018, 86(10):658.
[8] 陈锦环.妊娠期维生素D水平与妊娠结局的相关性研究[D].福州:福建医科大学, 2017.
[9] LI Z, YI H, LI J.Correlation of serum 25-hydroxyvitamin-D3, hs-CRP, and homocysteine in women with gestational diabetes mellitus[J].Archives of Medical Science, 2021, 48(102):58-62.
[10] 王孝君, 谭先凤, 段昆茂, 等.孕妇血清25-羟维生素D3水平与妊娠期糖尿病的相关性[J].中国妇幼保健, 2020, 35(13):2372-2375.
[11] 尹爱青, 周玉芬.妊娠期糖尿病患者血清25-羟维生素D3 C-反应蛋白及血脂水平分析[J].中国妇幼保健, 2020, 35(24):4710-4712.
[12] 张艳梅, 宋晓平, 黄莺.血清25-羟维生素D对妊娠期糖尿病的预测价值[J].中国医药, 2019, 14(11):1707-1710.
[13] 姚小艳, 陈君.上海地区孕妇维生素D水平调查及其与妊娠期糖尿病发生的相关性研究及其预测价值探索[J].诊断学理论与实践, 2019, 18(6):634-639.
[14] 施丹丹, 张若曦.母体血清25-羟维生素D3水平与妊娠期糖尿病发病的相关性[J].上海医学, 2019, 42(4):198-202.
[15] 卢云飞, 纪美晶, 王锐, 等.孕妇基础25-羟维生素D水平与孕中期血脂代谢及妊娠期糖尿病相关性研究[J].河北医药, 2018, 40(21):3245-3248.
[16] 周剑利, 刘聪慧, 赵楠楠.妊娠期糖尿病患者妊娠中期血清25-羟维生素D3与血脂水平及其在发病中的作用[J].中国妇幼保健, 2017, 32(19):4657-4659.
[17] 程梦笑, 董莉, 张月霞.妊娠期糖尿病患者血清25(OH)D3、脂联素、内脂素、瘦素水平变化分析[J].临床和实验医学杂志, 2021, 20(7):756-759.
[18] 张艳玲.血清25-羟基维生素D水平与肥胖、空腹血糖、血压及血脂的相关性研究[D].济南:山东大学, 2014.
[19] ALKHATATBEH M J, ABDUL-RAZZAK K K.Association between serum 25 hydroxyvitamin D, hemoglobin A1c and fasting blood glucose levels in adults with diabetes mellitus[J].Biomedical Reports, 2018, 9(6):145-147.
[20] 张文蓉, 王苏建, 史剑雷, 等.25-(OH)-D3、Sfrp-5和Nesfatin 1的表达水平与GDM发病的相关性分析[J].河北医药, 2021, 43(9):1347-1349.
[21] CHEN W, LI Y, GAO B, et al.Serum 25-hydroxyvitamin D levels in relation to lipids and clinical outcomes in pregnant women with gestational diabetes mellitus:an observational cohort study[J].BMJ Open, 2020, 10(11):e039905.
[22] 陈寒, 刘海艳, 宋慧颖, 等.妊娠早期血清维生素D水平与妊娠期糖尿病发病率和严重程度的关系[J].中国生育健康杂志, 2020, 31(2):123-126. |